Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor CellsDominique Verhelle, Kyle Chan, Laura G. Corral et al.|Cancer Research|2007Cited by 232
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cellsLaure A Moutouh-de Parseval, Kyle Chan, Dominique Verhelle et al.|Journal of Clinical Investigation|2008Cited by 180
Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic MechanismLaure Escoubet‐Lozach, Dominique Verhelle, Anita K. Gandhi et al.|Cancer Research|2009Cited by 170
Immunomodulatory Drug CC-4047 is a Cell-type and Stimulus-Selective Transcriptional Inhibitor of Cyclooxygenase 2Gregory D. Ferguson, Kyle Chan, Kristen Jensen-Pergakes et al.|Journal of Clinical Immunology|2007Cited by 32
Supplementary Figure 1 from Pomalidomide and Lenalidomide Induce p21<sup>WAF-1</sup> Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic MechanismLaure Escoubet‐Lozach, Dominique Verhelle, I-Lin Lin et al.|Unknown|2023Cited by 0